Search

Filters

Clear Filters
3:25 PM - 3:30 PM ET

1046 - Hematologic Toxicity, Treatment Completion Time, and Dosimetric Comparison between Proton and Photon Craniospinal Irradiation in Pediatric Tumor Patients: A Propensity Score-Matched Study
Speaker: Li, Ran, PhD - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan, Shandong
3:30 PM - 3:35 PM ET

1047 - Predicting Survival and Treatment Completion of Proton Craniospinal Irradiation in Leptomeningeal Disease: A Prognostic Nomogram
Speaker: Kanala, Tejaswi, MD, MBBS - MD Anderson Cancer Center, Houston, TX
3:10 PM - 3:20 PM ET

105 - Brachytherapy Versus External Beam Dose-Escalated Boost for Intermediate-Risk Prostate Cancer: Definitive Results of the GETUG P05 Trial
Speaker: Lapierre, Ariane, MD, PhD - Hospices Civils de Lyon, Pierre Benite, Rhône
8:05 AM - 8:10 AM ET

105 - Brachytherapy Versus External Beam Dose-Escalated Boost for Intermediate-Risk Prostate Cancer: Definitive Results of the GETUG P05 Trial
Speaker: Lapierre, Ariane, MD, PhD - Hospices Civils de Lyon, Pierre Benite, Rhône
3:10 PM - 3:15 PM ET

1050 - Five-Year Outcomes from a Prospective Trial of MR-Guided SBRT with Focal DIL Boost for Intermediate-Risk Prostate Cancer
Speaker: Goglia, Alexander, MD, PhD - Memorial Sloan Kettering Cancer Center, New York, NY
3:20 PM - 3:25 PM ET

1052 - Results of a Phase 2 Trial of Prostate SBRT with Integrated Tumor Boost and Dose Reduction at Urethra, Bladder and Rectal Interfaces
Speaker: Wilson, Trevor, MD - University of Wisconsin, Madison, WI
3:25 PM - 3:30 PM ET

1053 - Phase II Study of Stereotactic Body Radiation Therapy with Simultaneous Integrated Boost (SBRT-SIB) Delivered on an MR-LINAC for Intermediate and High Risk Prostate Cancer: 2 Year Outcomes
Speaker: Weg, Emily, MD - Weill Cornell Medicine, New York, NY
3:40 PM - 3:50 PM ET

1054 - Ten-Year Outcomes of Elective Upper-Neck vs. Whole-Neck Irradiation for the Uninvolved Neck in Nasopharyngeal Carcinoma Patients with N0-1 or Unilateral N3 Disease and High Pretreatment Plasma Epstein-Barr Virus DNA Load
Speaker: Huang, Chenglong, MD - Sun Yat-Sen University Cancer Center, Guang Dong Province, Guangdong
3:05 PM - 3:10 PM ET

1055 - A Multicenter, Randomized Controlled Phase III Trial of TPF Induction Chemotherapy vs. PF Adjuvant Chemotherapy Combined with Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: Long-Term Follow-up Analysis
Speaker: Jin, Feng, BS - Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou
3:10 PM - 3:15 PM ET

1056 - Evaluating Changes in Tumor Volumes Following Expert Interpretation of Planning Imaging in Head and Neck Cancer Radiotherapy
Speaker: Belliveau, Colin, MD - Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, QC
3:15 PM - 3:20 PM ET

1058 - Similar Overall Survival in Oropharyngeal Cancer Patients Treated with IMRT vs. Proton Therapy
Speaker: Wu, Yingzhi, MSN - Memorial Sloan Kettering Cancer Center, New York, NY
3:20 PM - 3:25 PM ET

1059 - Proton Beam Therapy vs. IMRT for Nasopharyngeal Carcinoma: Differential Late Toxicity Profile at 5 Years
Speaker: Taghizadeh Mortezaei, Nima, MD - Massachusetts General Hospital, Boston, MA